Clinical Reminders VA-MISC UPDATE 9 Install Guide · 4 update_2_0_83 install guide october 2019 134...

Update _2_0_83

Clinical Reminders

VA-MISC UPDATE 9

Install Guide

October 2019

Product Development

Office of Information Technology

Department of Veterans Affairs

ii Update_2_0_83 Install Guide October 2019

Table of Contents

INTRODUCTION .......................................................................... 1

INSTALL DETAILS ...................................................................... 1

INSTALL EXAMPLE .................................................................... 8

POST INSTALLATION ............................................................... 18

October 2019 Update _2_0_83 Install Guide 1

Introduction

This update contains 16 changes to existing reminder content. Click the link below to see a

detailed description of the changes.

MISC UPDATE 9 CHANGES

UPDATE_2_0_83 contains 1 Reminder Exchange entry:

UPDATE_2_0_83 MISC UPDATE 9

The exchange file contains the following components: MH TESTS AND SURVEYS PHQ9 TIU TEMPLATE FIELD 1 VA SP 3 LINES 2 VA-OSP WARNING SIGNS 3 VA-PSF DO NOT TYPE INFORMATION IN THE BOX 4 VA-PSF CHECK ONLY ONE 5 HBV FDA BOXED WARNING ANTI-CD20 6 HBV AASLD GUIDELINES 7 VA-MCC DIRECTIVE 8 BLANK TEXT FIELD FOR DIALOGS 9 VA-LIPID MGMT GUIDANCE 10 RX STATIN MOD/HI DOSE 11 AH-BPR BURN PIT REGISTRY 12 VA-OPIOID NALOXONE AUTO 13 VA-OPIOID NALOXONE NASAL 14 VA-OPIOID INTRO TO NALOXONE PRESCRIBE 15 VA-OPIOID INTRO TO NALOXONE DISORDER 16 VA-OPIOID SAFETY EDUCATION SPANISH 17 VA-OPIOID SAFETY EDUCATION ENGLISH 18 VA-OPIOID OVERDOSE ED SPANISH 19 VA-OPIOID OVERDOSE ED ENGLISH 20 VA-OPIOID TAPER 21 BLANK SPACE1 22 VIS HPV GARDASIL-9 23 IM VIS HPV GARDASIL-9 DT 24 IM COMMENT COMPLICATONS 25 IM HPV LOT# EXP DATE 26 IM HPV MANUF 27 IM INJECTION SQ SITE 28 IM INJECTION RIGHT/LEFT 29 CDC HPV VACCINE RECOMMENDATIONS 30 NCP HPV GUIDANCE IMMUNIZATION HPV9

http://vista.med.va.gov/reminders/UPDATE_2_0_83_CHANGES.pdf

2 Update_2_0_83 Install Guide October 2019

HPV, UNSPECIFIED FORMULATION HPV, BIVALENT HPV, QUADRIVALENT HEALTH FACTORS 31 LIPID MED INTERVENTIONS 32 DECLINES STATIN ADJUSTMENT 33 DECLINES STATIN THERAPY 34 REFUSED LIPID MED ADJUSTMENT 35 VA-REMINDER UPDATES 36 VA-UPDATE_2_0_83 37 VA-SUICIDE WARNING SIGNS [C] 38 VA-SUICIDE WARN UNKNOWN 39 VA-SUICIDE WARN INCREASED ISOLATION 40 VA-SUICIDE WARN DIRECT OTHER 41 VA-SUICIDE WARN IND SUBSTANCE ABUSE 42 VA-SUICIDE WARN IND RECKLESS 43 VA-SUICIDE WARN IND SLEEP DISTURBANCES 44 VA-SUICIDE WARN IND HOPELESSNESS 45 VA-SUICIDE WARN IND ANXIETY 46 VA-SUICIDE WARN DIRECT COMMUNICATION 47 VA-SUICIDE WARN IND GUILT 48 VA-SUICIDE WARN DIRECT SEEK ACCESS 49 VA-SUICIDE WARN DIRECT PREPARATIONS 50 VA-SUICIDE WARN IND ANGER 51 VA-SUICIDE WARN NONE 52 VA-SUICIDE RISK ASSESSMENT [C] 53 VA-HISTORY OF SUICIDE ATTEMPTS NO 54 VA-SUICIDE PREP BEHAVIOR NO 55 VA-PTSD PSF 56 VA-PSF Social Support-Understands 57 VA-TH VVC 58 VA-TH VVC CONFIRMED 59 INCORRECT DIAGNOSES 60 VA-INCORRECT REVASCULARIZATION CODE 61 INCORRECT DIAGNOSIS OF ATHEROSCLEROSIS 62 VA-INCORRECT DIABETES DIAGNOSIS 63 STATIN - ON HIGHEST TOLERATED DOSE 64 VA-STATIN LIFE EXPECTANCY < 2 YEARS 65 LIPID LOWERING MEDS ADJUSTED 66 OUTSIDE STATIN - MODERATE OR HIGH DOSE 67 LIPID MEDS NON-ADHERENCE 68 STATIN - ADR TO ALL AVAILABLE 69 STATIN - TEMPORARY CONTRAINDICATION 70 STATIN RX DOSE REVIEWED AND UPDATED 71 HT CONTINUUM OF CARE (CCF) 72 HT BATHING HELP/SUPRVISION LAST 7D-NO 73 VA-STATIN NON-VA MED VERIFIED 74 LIPID LOWERING MEDS INITIAL ORDER 75 REMINDER FACTORS 76 LIFE EXPECTANCY < 6 MONTHS 77 VA-NALOXONE 78 VA-NALOXONE ED-TEACH BACK 79 VA-NALOXONE RESOURCES-OTHER


80 VA-NALOXONE VIDEO-AUTO-INJECTOR 81 VA-NALOXONE VIDEO-SPRAY 82 VA-NALOXONE VIDEO-RX OPIOIDS 83 VA-NALOXONE VIDEO-OUD 84 VA-NALOXONE RESOURCES-DVD 85 VA-NALOXONE RESOURCES-OPIOID SAFETY 86 VA-NALOXONE RESOURCES-OD PREVENTION 87 VA-NALOXONE ED TO CAREGIVER OR OTHER 88 VA-NALOXONE ED TO PATIENT 89 VA-NALOXONE NOT NEEDED 90 VA-PATIENT DECLINED NALOXONE 91 VA-NALOXONE RX REQUEST PROVIDER NOTIFIED 92 VA-NALOXONE RX ORDERED 93 VA-NALOXONE ADMINISTERED TO PATIENT 94 VA-OVERDOSE REFERRAL DECLINED 95 VA-OVERDOSE REFERRAL NONE 96 VA-OVERDOSE REFERRAL OTHER 97 VA-OVERDOSE REFERRAL PAIN 98 VA-OVERDOSE REFERRAL SUD 99 VA-OVERDOSE REFERRAL PCMHI/MH 100 VA-OVERDOSE REFERRAL PCP 101 VA-NALOXONE IMMEDIATE CARE NEEDED-NO 102 VA-OVERDOSE IMMEDIATE CARE NEEDED OTHER 103 VA-OVERDOSE IMMEDIATE CARE NEEDED ED 104 VA-OVERDOSE IMMEDIATE CARE NEEDED PCMHI 105 VA-NALOXONE IMMEDIATE CARE NEEDED-YES 106 VA-NALOXONE REFERRALS 107 VA-NALOXONE IMPACT OR TX CHANGE-NO 108 VA-NALOXONE IMPACT OR TX CHANGE-YES 109 VA-NALOXONE IMPACT OR TX CHANGE 110 VA-NALOXONE TREATMENT PLAN 111 VA-OVERDOSE OPIOID TAPER RF-DISCUSS RISK 112 VA-OVERDOSE RISK FACTOR OPIOID TAPERING 113 VA-OVERDOSE ABSTINENCE RF-DISCUSS RISK 114 VA-OVERDOSE RISK FACTOR PRIOR ABSTINENCE 115 VA-OVERDOSE PREV OD RF-DISCUSS PT SAFETY 116 VA-OVERDOSE RISK FACTOR PRIOR OVERDOSE 117 VA-OVERDOSE SEDATIVE RF-DISCUSS TAPER 118 VA-OVERDOSE SEDATIVE RF-DISCUSS ALT TX 119 VA-OVERDOSE SEDATIVE RF-DISCUSS RISKS 120 VA-OVERDOSE RISK FACTOR SEDATIVES 121 VA-OVERDOSE RISK FACTOR OTHER 122 VA-OVERDOSE RISK FACTOR FINANCE 123 VA-OVERDOSE RISK FACTOR FAMILY 124 VA-OVERDOSE RISK FACTOR HOMELESS 125 VA-OVERDOSE RISK FACTOR HIV 126 VA-OVERDOSE RISK FACTOR ED 127 VA-OVERDOSE RISK FACTOR FALLS 128 VA-OVERDOSE RISK FACTOR MEDICAL 129 VA-OVERDOSE DUAL OPI RX RF-OTHER 130 VA-OVERDOSE DUAL OPI RX RF-SLOW TAPER 131 VA-OVERDOSE DUAL OPI RX RF-CHANGE RX TX 132 VA-OVERDOSE DUAL OPI RX RF-REVIEWCONSENT 133 VA-OVERDOSE DUAL OPI RX RF-NO TX CHANGE


134 VA-OVERDOSE DUAL OPI RX RF-NONOPIOID TX 135 VA-OVERDOSE DUAL OPI RX RF-CARE COORD 136 VA-OVERDOSE DUAL OPI RX RF-ALT STRATEGY 137 VA-OVERDOSE DUAL OPI RX RF-DISCUSS RISK 138 VA-OPIOID SOURCE VA AND NON VA 139 VA-OVERDOSE NONVA OPI RX RF-NONOPIOID TX 140 VA-OVERDOSE NONVA OPI RX RF-CARE COORD 141 VA-OVERDOSE NONVA OPI RX RF-ALT STRATEGY 142 VA-OVERDOSE NONVA OPI RX RF-DISCUSS RISK 143 VA-OPIOID SOURCE NON VA 144 VA-OVERDOSE VA OPIOID RX RF-ALT STRATEGY 145 VA-OVERDOSE VA OPIOID RX RF-OTHER 146 VA-OVERDOSE VA OPIOID RX RF-SLOW TAPER 147 VA-OVERDOSE VA OPIOID RX RF-CHANGE RX TX 148 VA-OVERDOSE VA OPIOID RX RF-NO TX CHANGE 149 VA-OVERDOSE VA OPIOID RX RF-NONOPIOID TX 150 VA-OVERDOSE VA OPIOID RX RF-DISCUSS RISK 151 VA-OPIOID SOURCE VA 152 VA-OVERDOSE RISK FACTOR PRE OPIOIDS 153 VA-OVERDOSE NONRX OPIOID RF-DISCUSS RISK 154 VA-OVERDOSE RISK FACTOR NON PRE OPIOIDS 155 VA-OVERDOSE MH RF-PT DECLINES MH TX 156 VA-OVERDOSE MH RF-MH TX REFERRAL 157 VA-OVERDOSE MH RF-MH ADDRESSED 158 VA-OVERDOSE RISK FACTOR MENTAL HEALTH 159 VA-OVERDOSE PATIENT DECLINES SUD TREAT 160 VA-OVERDOSE SUD RF-SUD TX REFERRAL 161 VA-OVERDOSE SUD RF-SUD ADDRESSED 162 VA-NALOXONE OD RF SUD-SUD TX IN TX PLAN 163 VA-OVERDOSE RISK FACTOR SUD 164 VA-NALOXONE RISK FACTORS 165 VA-NALOXONE USED 166 VA-SUICIDE BEHAVIOR AND OVERDOSE REPORT 167 VA-SBOR OVERDOSE RISK FACTORS 168 VA-SBOR METHOD TYPE OVERDOSE 169 VA-HPV 170 VA-HPV DECLINED PERMANENTLY 171 VA-HPV PRECAUTION 172 VA-HPV CONTRAINDICATED 173 VA-HPV DECLINED REMINDER SPONSOR 174 VHA Cardiology Services 175 VA National Center for Health Promotion and Disease Prevention (NCP) 176 Office of Mental Health Services 177 Mental Health Services 178 Office of Connected Care 179 WOMEN VETERANS HEALTH PROGRAM 180 Office of Patient Care Services 181 Office of Public Health and Environmental Hazards 182 VHA Office of Connected Care (10P8) 183 Office of Quality & Performance 184 National Center for Health Promotion and Disease


Prevention (NCP) REMINDER COMPUTED FINDINGS VA-AGE VA-REMINDER DEFINITION VA-FILEMAN DATE VA-ALLERGY VA-ASU USER CLASS REMINDER TAXONOMY 185 VA-PNEUMOC DZ RISK - CHEMOTHERAPY 186 VA-STATIN OTHER REVASCULARIZATION 187 VA-STATIN PCI 188 VA-STATIN CABG 189 VA-IHD AND ASVD 190 VA-DIABETES HEDIS PROB LIST 191 VA-DIABETES HEDIS 192 VA-TERMINAL CANCER PATIENTS REMINDER TERM 193 VA-STATIN DECLINES 194 VA-REMINDER UPDATE_2_0_83 195 VA-MH PHQ9 COMPLETED 196 VA-HPV DECLINE VACCINE PERMANENTLY (BL) 197 VA-PNEUMOC DZ RISK - CHEMO/IMMUNOSUPP DRUGS 198 VA-BL STATIN RX ACTIVE/SUSPENDED 199 VA-BL LDL REVASCULARIZATION 200 VA-IHD/ASVD DX INCORRECT 201 VA-IHD AND ASVD 202 VA-DIABETES DX INCORRECT 203 VA-DIABETES MEDICATIONS 204 VA-BL LDL DM AND CV DISEASE 205 VA-BL LDL CV DISEASE ONLY 206 VA-BL LDL DIABETES DX ONLY 207 VA-STATIN DRUGS NON-VA 208 VA-BL STATIN INPT/OUTPT RX 209 VA-STATIN DRUGS 210 VA-BL LDL STATIN NON-VA MED VERIFIED 211 VA-LDL IHD/ASCVD AGE RANGE 212 VA-LDL DIABETES AGE RANGE 213 VA-STATIN TEMPORARY CONTRAIND 214 VA-STATIN ADR ALL HF 215 VA-STATIN ADR 216 VA-ORDER LIPID PROFILE HEALTH FACTOR 217 VA-LIPID PROFILE ORDERABLE 218 VA-STATIN NON-VA MOD/HI DOSE THERAPY 219 VA-STATIN ON HIGHEST TOLERATED DOSE 220 VA-LDL NON-ADHERENCE WITH RX 221 VA-STATIN ADD/ADJUST 222 VA-OUTSIDE LDL >129 223 VA-OUTSIDE LDL 120-129 224 VA-OUTSIDE LDL 100-119 225 VA-LDL 226 VA-OUTSIDE LDL <100


227 VA-STATIN MODERATE DOSE 228 VA-STATIN HIGH DOSE 229 VA-CHD RISK <=20% 230 VA-CHD RISK >20% 231 VA-LIFE EXPECTANCY < 6 MONTHS 232 VA-NALOXONE USE 233 VA-BL NALOXONE GIVEN TO PATIENT 234 VA-HPV VACCINES 235 VA-HPV ADMINISTRATION SUPPRESSION 236 VA-HPV BL SERIES 2 VACCINES 237 VA-HPV ORDER SUPPRESSION 238 VA-HPV VACCINE PRECAUTION 239 VA-HPV VACCINE ORDERED 240 VA-HPV VACCINE DECLINED 241 VA-HPV VACCINE CONTRAINDICATED 242 VA-HPV VACCINE DECLINED PERMANENTLY 243 VA-HPV VACCINES SERIES 2 244 VA-HPV VACCINES SERIES COMPLETE REMINDER DEFINITION 245 VA-BL LDL REVASCULARIZATION 246 VA-BL LDL DM AND CV DISEASE 247 VA-BL LDL CV DISEASE ONLY 248 VA-BL LDL DIABETES DX ONLY 249 VA-BL LDL NON-VA STATIN VERIFIED 250 VA-LIPID STATIN RX CVD/DM (VER1.0) 251 VA-NALOXONE OBJECT 252 VA-NALOXONE TREATING PROVIDER 253 VA-HPV PRIOR IMMUNIZATIONS (OBJECT) 254 VA-HPV BL SERIES 2 VACCINES 255 VA-HUMAN PAPILLOMAVIRUS (HPV) IMMUNIZATION HEALTH SUMMARY COMPONENT CLINICAL REMINDERS FINDINGS PCE HEALTH FACTORS SELECTED HEALTH SUMMARY TYPE 256 VA-NALOXONE 257 VA-NALOXONE DATE 258 HPV IMMUNIZATIONS HEALTH SUMMARY OBJECTS 259 VA-NALOXONE (TIU) 260 VA-NALOXONE DATE (TIU) 261 HPV IMMUNIZATIONS (TIU) TIU DOCUMENT DEFINITION 262 VA-NALOXONE 263 VA-NALOXONE DATE 264 HPV IMMUNIZATIONS REMINDER DIALOG 265 PXRM PHQ9 MONITORING RESULT ELEMENT 1 266 VA-GP MISC UPDATE 9


267 VA-LIPID STATIN RX CVD/DM 268 VA-NALOXONE TREATMENT PROVIDER 269 VA-HUMAN PAPILLOMAVIRUS (HPV) VACCINE

Install Details This update is being distributed as a web host file. The address for the host file is:

http://vista.med.va.gov/reminders/UPDATE_2_0_83.PRD

If your site is unable to use LWH, you will have a vista mail message with

subject of UPDATE_2_0_83.

The file will be installed using Reminder Exchange, programmer access is not required.

Installation:

=============

This update can be loaded with users on the system. Installation will take less than 30 minutes.

Pre-Install Do a reminder term inquiry on VA-PNEUMOC DZ RISK – CHEMO/IMMUNOSUPP DRUGS

and print this out to do a comparison once the update is installed.



Install Example To Load the Web Host File. Navigate to Reminder exchange in Vista

At the Select Action: prompt, enter LWH for Load Web Host File

At the Input the url for the .prd file: prompt, type the following web address:


If your site is unable to use LWH functionality, you will use LMM option to load the exchange

file that was sent to you by HPS CLIN2 staff. If you do not have it, please send us an email

requesting this prd file.

You should see a message at the top of your screen that the file successfully loaded.

General rules for installing:

1. If a component exists already, but is different, use the OVERWRITE action

2. For reminder terms below, use the OVERWRITE action. From Pre-Install, you will

have needed to print out the inquiry for VA-PNEUMOC DZ RISK –

CHEMO/IMMUNOSUPP DRUGS to do comparison after install.

a. VA-PNEUMOC DZ RISK – CHEMO/IMMUNOSUPP DRUG

b. VA-HPV DECLINE VACCINE PERMANENTLY (BL)

c. VA-MH PHQ9 COMPLETED

3. For other reminder terms use the MERGE action to make sure you don’t overwrite

your local mapped items in the terms

4. For Reminder Definition VA-LIPID STATIN RX CVD/DM (VER1.0), only the

definition needs to be OVERWRITTEN. You can skip the dialog install

5. For Reminder Definition VA-HUMAN PAPILLOMAVIRUS (HPV)

IMMUNIZATION, only the definition needs to be OVERWRITTEN. You can skip

the dialog install

6. For Reminder Definition VA-NALOXONE TREATING PROVIDER, only the

definition needs to be OVERWRITTEN. You can skip the dialog install

Install the exchange file:

Search and locate an entry titled UPDATE_2_0_83 MISC UPDATE 9 in reminder exchange.


At the Select Action prompt, enter IFE for Install Exchange File Entry

Enter the number that corresponds with your entry UPDATE_2_0_83 MISC UPDATE 9 (in

this example it is entry 443. It will vary by site. Make sure you are using exchange file dated 10/02/2019@09:04:44


At the Select Action prompt, type IA to install all components.

Again, general rules are:

1. If a component doesn’t exist, INSTALL action

2. If a component exists, but is different OVERWRITE action

3. All Reminder Terms that exist, but are different should use the MERGE action

4. For Reminder Definition VA-LIPID STATIN RX CVD/DM (VER1.0), you will only

need to OVERWRITE the definition. Dialog Install should be SKIPPED

5. For Reminder Definition VA-NALOXONE TREATING PROVIDER, you will only need

to OVERWRITE the definition. Dialog Install should be SKIPPED

6. For Reminder Definition VA-HUMAN PAPILLOMAVIRUS (HPV) IMMUNIZATION,

you will only need to OVERWRITE the definition. Dialog Install should be SKIP


At this point, you will begin installing the dialogs in the exchange file.

You will then be prompted to install the FIRST reminder dialog:

At the Select Action prompt, type IA to install the dialog – VA-GP MISC UPDATE 9

Select Action: Next Screen// IA Install All

Install reminder dialog and all components with no further changes: Y// Yes

This will install all but one of the components needing updating.


After the dialog installs, you will be returned to this prompt, at the Select Action prompt, type Q

to quit.


You will be promped to install the NEXT reminder dialog component:

At the Select Action prompt, type IA to install the dialog – PXRM PHQ9 MONITORING

RESULT ELEMENT 1

Select Action: Next Screen// IA Install All

Install reminder dialog and all components with no further changes: Y// ES


When the dialog has completed installation, you will then be returned to this screen. At the

Select Action prompt, type Q.


You will be prompted to install the NEXT reminder dialog component – YOU

DO NOT NEED TO INSTALL THIS:

At the Select Action prompt, type Q.





You may then be prompted to choose an action for Health Summary

Type/Object items. Select OVERWRITE on these


After all Dialogs have been Installed, you will be returned to this screen

At the Select Action prompt, type Q to quit

Install Completed

Post Installation

1. Verify that all changes have taken place by doing comparison to what you see with the

screenshots listed in the embedded document

MISC UPDATE 9 CHANGES

NOTE: If there are any questions or problems during the installation, please notify your local IT

support to log a national help desk ticket or contact the VA Service Desk and have them submit a

national ticket to:

Category: Enterprise Applications

Subcategory: Applications

http://vista.med.va.gov/reminders/UPDATE_2_0_83_CHANGES.pdf


Enterprise Application: VistA - Clinical Reminders

Assignment Group: NTL SUP Clin 2

Clinical Reminders VA-MISC UPDATE 9 Install Guide · 4 update_2_0_83 install guide october 2019 134...

Documents

Transcript of Clinical Reminders VA-MISC UPDATE 9 Install Guide · 4 update_2_0_83 install guide october 2019 134...